Nachrichten zur Hims & Hers Health Inc. Aktie

After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?

Hims & Hers strong performance involves much more than just GLP-1 drugs.…

After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy? @themotleyfool #stocks $HIMS

Hims & Hers strong performance involves much more than just GLP-1 drugs.…

Hims & Hers health chief medical officer Carroll sells $331,093 in stock By Investing.com

Hims & Hers health chief medical officer Carroll sells $331,093 in stock…

Hims & Hers CEO Andrew Dudum sells $6.9 million in stock By Investing.com

Hims & Hers CEO Andrew Dudum sells $6.9 million in stock…

Hims & Hers chief commercial officer sells $45,188 in stock By Investing.com

Hims & Hers chief commercial officer sells $45,188 in stock…

Hims & Hers Health Inc (HIMS) Stock Price Up 2.82% on Nov 7

Shares of Hims & Hers Health Inc (HIMS) surged 2.82% in mid-day trading on Nov 7. The stock reached an…

Seaport Res Ptn Has Positive Outlook of HIMS FY2024 Earnings

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their FY2024…

Stock Traders Purchase High Volume of Hims & Hers Health Call Options (NYSE:HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw unusually large options trading activity on Wednesday. Stock investors…

Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy

According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might…

Hims & Hers: Why This Healthcare Stocks Growth Makes It a Buy

Most investors would look at an earnings announcement as a past event, connecting the current price action in the stock…

Hims & Hers Health Third Quarter 2024 Earnings: Beats Expectations

Hims & Hers Health ( NYSE:HIMS ) Third Quarter 2024 Results Key Financial Results Revenue: US$401.6m (up 77% from 3Q...…

Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Hims & Hers Health, Inc. ( NYSE:HIMS ) investors will be delighted, with the company turning in some strong numbers...…

Leerink Partnrs Has Bullish Estimate for HIMS Q4 Earnings

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Analysts at Leerink Partnrs upped their Q4 2024 earnings…

Q4 EPS Estimate for Hims & Hers Health Boosted by Analyst

Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Research analysts at Seaport Res Ptn upped their Q4…

Hims & Hers stock rallies amidst increased revenue, GLP-1 generic

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of…

Hims & Hers Health (NYSE:HIMS) Announces Quarterly Earnings Results, Beats Expectations By $0.26 EPS

Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.32…

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24 By Investing.com

Hims & Hers stock maintains buy rating with TD Cowen after solid 3Q24…

Whats Going On With Hims & Hers Health Stock Tuesday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and…

Hims & Hers Health: Another Blowout Quarter Ignored (NYSE:HIMS)

Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the market. Learn more HIMS…

Hims & Hers will start selling a generic weight loss drug

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of…

Hims & Hers will start selling a generic weight loss drug

The telehealth company will start offering a generic version of liraglutide in 2025 as consumers continue to struggle to secure…

Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Better-Than-Expected Earnings

Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Strong Earnings…

Revenue Soars 77% for Hims & Hers Health, Inc. in Q3 2024

In the third quarter, the brands eclipsed two million subscribers on its platform, with more than 1 million utilizing a…

Hims & Hers Reports High Success Rate in GLP-1 Program

Hims & Hers has released a white paper showing that 87% of its GLP-1 weight loss program customers are close…

Hims & Hers Stock Soars: First Generic Weight Loss Drug to Shake Up Billion-Dollar Market

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…

Hims & Hers Stock Soars: First Generic Weight Loss Drug to Shake Up Billion-Dollar Market

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novos weight-loss dominance…

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…

Hims & Hers Soars Pre-Market After Analysts Boost Price Targets On Strong Q3 Performance

Hims & Hers Health raised its full-year sales guidance to $1.46 billion to $1.465 billion, up from a forecast in…

Hims & Hers price target raised to $32 from $28 at Seaport Research

Seaport Research raised the firm’s price target on Hims Hers to $32 from $28 and keeps a Buy rating…

Canaccord Genuity Group Increases Hims & Hers Health (NYSE:HIMS) Price Target to $28.00

Canaccord Genuity Group lifted their target price on Hims & Hers Health from $24.00 to $28.00 and gave the company…

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator…

Stocks making the biggest moves premarket: Trump Media, Hims & Hers, Palantir and more

These are the stocks posting the largest moves in premarket trading.…

Hims & Hers boomt: Anhaltender GLP-1-Engpass und kostengünstige Alternativen treiben Nachfrage im Gewichtsmanagement

Hims & Hers Health, Inc. hat im 3. Quartal 2024 beeindruckende Ergebnisse erzielt und die Erwartungen der Analysten deutlich übertroffen.…

Hims & Hers price target raised to $21 from $18 at Piper Sandler

Piper Sandler analyst Korinne Wolfmeyer raised the firm’s price target on Hims Hers to $21 from $18 and keeps…

Hims & Hers to launch a generic for Novo’s older GLP-1

Hims & Hers Health (NYSE:HIMS) is gearing up to launch an off-patent version of Novo Nordisks (NVO) (OTCPK:NONOF) older GLP-1…

Hims & Hers to launch a generic GLP-1 (HIMS:NYSE)

Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version…

Hims & Hers price target raised to $28 from $24 at Canaccord

Canaccord raised the firm’s price target on Hims Hers to $28 from $24 and keeps a Buy rating on…

Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025

Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a generic…

Hims and Hers stock gets boost from BofA as marketing spend fuels user growth By Investing.com

Hims and Hers stock gets boost from BofA as marketing spend fuels user growth…

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion By Investing.com

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion By Investing.com

Earnings call: Hims & Hers reports robust Q3 growth, plans for expansion…

Hims & Hers Health Inc (HIMS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion

With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…

Vanguard Group Incs Strategic Acquisition in Hims & Hers Health Inc

Overview of the Recent Transaction On September 30, 2024, Vanguard Group Inc, a prominent investment firm, expanded its portfolio by…

Hims & Hers Health Inc (HIMS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

With a 77% revenue increase and a growing subscriber base, Hims & Hers Health Inc (HIMS) continues to innovate in…

Hims & Hers Health Reports Strong Q3 2024 Growth

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information…

Hims & Hers: A Lot More Than Just GLP-1, And Its Proving Its Ability To Grow

…

Hims & Hers: A Lot More Than Just GLP-1, And Its Proving Its Ability To Grow (HIMS)

Hims & Hers strong Q3 results and revenue growth demonstrate its robust business. Click here to see why HIMS stock…

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

…

HIMS Stock Gains Following In Line Q3 Earnings, Gross Margin Contracts

Hims & Hers both revenue channels witness strong revenue growth on the back of solid product demand in the third…

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.

Hims & Hers Health (HIMS) shares jumped in extended trading after the company reported better than expected third quarter revenue…